Assuring the quality of clinical microbiology test results

Clinical Infectious Diseases

Volumn 47, Issue 8, 2008, Pages 1077-1082

  Wilson, Michael L ^a,b,c  

^a DENVER HEALTH AND HOSPITAL AUTHORITY   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c DENVER HEALTH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; ANTIBIOTIC SENSITIVITY; CLINICAL LABORATORY; COST CONTROL; HEALTH CARE PERSONNEL; HEALTH CARE QUALITY; HEALTH SURVEY; INFECTION; INFORMATION PROCESSING; MICROBIOLOGY; PATIENT CARE; PATIENT SAFETY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; QUALITY CONTROL; REVIEW;

CLINICAL LABORATORY TECHNIQUES; COMMUNICABLE DISEASES; HUMANS; QUALITY CONTROL; QUALITY OF HEALTH CARE;

EID: 53349109287     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/592071     Document Type: Review

References (42)

1. Wilson ML. General principles of specimen collection and transport. Clin Infect Dis 1996; 22:766-77.
2. Weinstein MP. Current blood culture methods and systems: clinical concepts, technology, and interpretation of results. Clin Infect Dis 1996; 23:40-6.
3. Pfaller MA, Rex JH, Rinaldi MG. Antifungal susceptibility testing: technical advances and potential clinical applications. Clin Infect Dis 1997; 24:776-84.
4. Pfaller MA, Herwaldt LA. The clinical microbiology laboratory and infection control: emerging pathogens, antimicrobial resistance, and new technology. Clin Infect Dis 1997; 25:858-70.
5. Reimer L, Carroll K. Microbiology and laboratory diagnosis of upper respiratory tract infections. Clin Infect Dis 1998; 26:742-8.
6. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: general principles and contemporary practices. Clin Infect Dis 1998; 26:973-80.
7. Doern GV. Detection of selected fastidious bacteria. Clin Infect Dis 2000; 30:166-73.
8. Jorgensen JH, Ferraro MJ. Antimicrobial susceptibility testing: special needs for fastidious organisms and difficult-to-detect resistance mechanisms. Clin Infect Dis 2000; 30:799-808.
9. Storch GA. Diagnostic virology. Clin Infect Dis 2000; 31:739-51.
10. Woods G. Susceptibility testing for mycobacteria. Clin Infect Dis 2000; 31:1209-15.
11. Infectious Diseases Society of America. Policy statement on consolidation of clinical microbiology laboratories. 2001; 32:604.
12. Peterson LR, Hamilton JD, Baron EJ, et al. Role of clinical microbiology laboratories in the management and control of infectious diseases and the delivery of health care. Clin Infect Dis 2001; 32:605-11.
13. Procop GW, Wilson M. Infectious disease pathology. Clin Infect Dis 2001; 32:1589-601.
14. Baron EJ. Rapid identification of bacteria and yeast: summary of a National Committee for Clinical Laboratory Standards Proposed Guideline. Clin Infect Dis 2001; 33:220-5.
15. Hale YM, Pfyffer GE, Salinger M. Laboratory diagnosis of mycobacterial infections: new tools and lessons learned. Clin Infect Dis 2001; 33:834-46.
16. Murdoch DR. Diagnosis of Legionella infection. Clin Infect Dis 2003;36:64-9.
17. Murdoch DR. Nucleic acid amplification tests. Clin Infect Dis 2003; 36:1162-70.
18. Wilson ML, Gaido L. Laboratory diagnosis of urinary tract infections in adult patients. Clin Infect Dis 2004; 38:1150-8.
19. Pien BC, Saah JR, Miller SE, Woods CW. Use of sentinel laboratories by clinicians to evaluate potential bioterrorism and emerging infections. Clin Infect Dis 2006; 42:1311-24.
20. Baron EJ. Implications of new technology for infectious diseases practice. Clin Infect Dis 2006; 43:1318-23.
21. Nolte FS. Case studies in cost effectiveness of molecular diagnostics for infectious diseases: pulmonary tuberculosis, enteroviral meningitis, and BK virus nephropathy. Clin Infect Dis 2006; 43:1463-7.
22. Jorgensen JH, Hindler JF. New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria. Clin Infect Dis 2007; 44:280-6.
23. Tenover FC. Rapid detection and identification of bacterial pathogens using novel molecular technologies: infection control and beyond. Clin Infect Dis 2007; 44:418-23.
24. Hindler JF, Stelling J. Analysis and presentation of cumulative antibiograms: a new consensus guideline from the clinical and laboratory standards institute. Clin Infect Dis 2007; 44:867-73.
25. Petti CA. Detection and identification of microorganisms by gene amplification and sequencing. Clin Infect Dis 2007; 44:1108-14.
26. Wilson ML, Winn W. Laboratory diagnosis of bone, joint, and soft tissue infections. Clin Infect Dis 2008; 46:453-7.
27. Werno AM, Murdoch DR. Laboratory diagnosis of invasive pneumococcal disease. Clin Infect Dis 2008; 46:926-32.
28. Clinical and Laboratory Standards Institute. Laboratory instrument implementation, verification, and maintenance; proposed guideline. 2nd ed. CLSI document GP27-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
29. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
30. Kaushal R, Bates DW. Computerized physician order entry (CPOE) with clinical decision support systems (CDSSs). In: Making health care safer: a critical analysis of patient safety practices: evidence report/ technology assessment. No. 43. Rockville, MD: AHRQ, 2001.
31. Clinical and Laboratory Standards Institute. Analysis and presentation of cumulative antimicrobial susceptibility test data; approved guideline. 2nd ed. CLSI document M39-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2005.
32. Faris B, Majumdar S. Audit on compliance of antibiotic prescribing for gram-negative bacteraemia with current Trust guidelines. RCPath Bulletin 2006; 134:78-9. Available at: http://www.rcpath.org/resources/pdf/ Audit_on_compliance_of_antibiotics_prescribing_for_gram- negative_bacteraemia_with_current_local_Trust_guidelines_Apr06.pdf. Accessed 14 May 2007.
33. Morris A, Wilson ML, Mirrett S, Reller LB. Rationale for selective use of anaerobic blood cultures. J Clin Microbiol 1993; 31:2110-3.
34. Dorsher CW, Rosenblatt JE, Wilson WR, Ilstrup DM. Anaerobic bacteremia: decreasing rate over a 15-year period. Rev Infect Dis 1991; 13:633-6.
35. Gomez J, Banos V, Ruiz J, et al. Clinical significance of anaerobic bacteremias in a general hospital: a prospective study from 1988 to 1992. Clin Investig 1993; 71:595-9.
36. Lombardi DP, Engleberg N. Anaerobic bacteremia: incidence, patient characteristics, and clinical significance. Am J Med 1992; 92:53-60.
37. Murray PR, Traynor P, Hopson D. Critical assessment of blood culture techniques: analysis of recovery of obligate and facultative anaerobes, strict aerobic bacteria, and fungi in aerobic and anaerobic blood culture bottles. J Clin Microbiol 1992; 30:1462-8.
38. Ortiz E, Sande MA. Routine use of anaerobic blood cultures: are they still indicated? Am J Med 2000; 108:445-7.
39. Zaidi AKM, Knaut AL, Mirrett S, Reller LB. Value of routine anaerobic blood cultures in pediatric patients. J Pediatr 1995; 127:263-8.
40. Lassmann B, Gustafson DR, Wood CM, Rosenblatt JE. Reemergence of anaerobic bacteremia. Clin Infect Dis 2007; 44:895-900.
41. Hecht DW. Routine anaerobic blood cultures: back where we started? Clin Infect Dis 2007; 44:901-3.
42. Miller LG, Perdreau-Remington F, Rieg G, et al. Necrotizing fasciitis caused by community-associated methicillin-resistant Staphylococcus aureus in Los Angeles. N Engl J Med 2005; 352:1445-53.